DMV snaps up NutrAward
It is estimated that one in every four adults has prehypertension, which is the gray zone between normal and high blood pressure. This group of people is the target group for products containing C12 Peption.
25/03/05 C12 Peption, DMV’s ingredient which supports the natural blood pressure mechanism, has won the NutrAward at the Nutracon/SupplyExpo held in Anaheim, California-USA.
The World Health Organisation estimates that in most countries up to 30% suffer from high blood pressure and a further 50 to 60% would be in better health if they controlled their blood pressure. It is estimated that one in every four adults has prehypertension, which is the gray zone between normal and high blood pressure. This group of people is the target group for products containing C12 Peption. “With C12 Peption, we provide our customers with a key ingredient to formulate highly successful and innovative products for the support of a natural blood pressure mechanism“, says Daniella Witte, Market Development Manager at DMV International.
“Winning the NutrAward is a great recognition for the innovative character of this product. The fact that both a scientific committee and the visitors selected C12 Peption as the winner proves the sound scientific basis and the market potential. The visitors of Nutracon/Supply Expo are in fact the potential buyers of C12 Peption”, according to Steven Braun, Director Food Systems & Nutrition at DMV International.
The attendees of Nutracon/Supply Expo 2005 and a scientific committee selected the winner of the Award. The scientific committee and the visitors selected C12 Peption from the three finalist products, based on the following criteria: (1) merit, (2) efficacy, (3) safety, (4) innovation, (5) market potential, and (6) it's ability to increase industry credibility.
